Quick Answer
CalciMedica, Inc. reported Stockholders Equity of -$6.64 million for fiscal year 2025.
CalciMedica, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$6.64M | -146.1% |
| 2024 | $14.41M | +76.7% |
| 2023 | $8.16M | +111.4% |
| 2022 | -$71.30M | -11.4% |
| 2021 | -$63.99M | -167.5% |
| 2020 | $94.79M | +192.1% |
| 2019 | -$102.95M | -54.1% |
| 2018 | -$66.79M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$268.0K | -103.0% | -104.4% |
| June 30, 2025 | $6.10M | -55.9% | -43.9% |
| March 31, 2025 | $10.89M | -36.9% | -24.4% |
| December 31, 2024 | $14.41M | +76.7% | +59.6% |
| September 30, 2024 | $9.03M | -25.7% | -34.7% |
| June 30, 2024 | $13.84M | -14.7% | -19.8% |
| March 31, 2024 | $17.25M | -21.7% | +111.4% |
| December 31, 2023 | $8.16M | +111.4% | -32.9% |
- CalciMedica, Inc. showed a decrease of -146.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, CalciMedica, Inc.’s stockholders equity has grown by 90.1% (from -$66.79 million to -$6.64 million).
- The most recent figure is from CalciMedica, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: